AdiBamnolkerDO

Internal Medicine • Oakland, CA

Hospitalist

Join to view full profile

Dr. Bamnolker is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bamnolker's full profile

Already have an account?

Office
3600 Broadway
Oakland, CA 94611

Education & Training

Ochsner Clinic FoundationResidency, Internal Medicine, 2019 - 2022
Touro University Nevada College of Osteopathic MedicineClass of 2019

Certifications & Licensure

CA State License 2022 - 2026
LA State License 2022 - 2023
American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

5 citations
Direct Oral Anticoagulants Versus Warfarin for Venous Thromboembolism Prophylaxis in Patients With Nephrotic Syndrome: A Retrospective Cohort Study.
Aminat Tijani, Eric M Coons, Britta Mizuki, Miranda Dermady, Katerina Stanilova
The Annals of Pharmacotherapy. 2023-07-01
45 citations
Timing of steroid initiation and response rates to immune checkpoint inhibitors in metastatic cancer.
Diana Maslov, Karine Tawagi, Madhav Kc, Victoria Simenson, Helen Yuan
Journal for Immunotherapy of Cancer. 2021-07-01

Journal Articles

Timing of steroid initiation and response rates to immune checkpoint inhibitors in metastatic cancer. Journal for Immunotherapy of Cancer.
Maslov DV, Tawagi K, Madhav KC, Simenson V, Yuan H, Parent C, Bamnolker A, Goel R, Blake Z, Matrana MR, Johnson DH., Journal for Immunotherapy of Cancer, 7/9/2021

Abstracts/Posters

Direct Oral Anticoagulants Versus Warfarin for Venous Thromboembolism Prophylaxis in Patients with Nephrotic Syndrome: A Retrospective Cohort Study
Stanilova K, Tijani AA, Coons EM, Casey A, Mizuki B, Dermady M, Bamnolker A, Alqudsi M, Velez JCQ, American Society of Nephrology, Abstract submitted 5/2022
Clinical outcomes for advanced hepatocellular carcinoma patients treated with systemic agents in real-world practice.
Tawagi K, Maslov DV, Madhav KC, Markabawi D, Mukkamala S, Farag F, Yuan H, Bamnolker A, Saeed R, Blake Z, Matrana M, & Johnson D., Journal of the National Comprehensive Cancer Network, American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, 3/2021
The impact of hypertension on response rates in patients with renal cell carcinoma.
Maslov DV, Tawagi K, Madhav KC, Goel R, Yuan H, Bamnolker A, Blake Z, Song W, Johnson D, & Matrana M., Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO) Genitourinary Annual Symposium, 2/2021
IMDC scores and clinical outcomes for renal cell carcinoma patients treated with 1st line NCCN guideline directed therapy in real-world practice.
Maslov DV, Tawagi K, Madhav KC, Goel R, Yuan H, Bamnolker A, Blake Z, Song W, Johnson D, & Matrana M., American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium, 2/2021
Impact of body mass index on survival rates in patients receiving immune checkpoint inhibitors.
Maslov DV, Tawagi K, Simenson V, Yuan H, Parent C, Bamnolker A, Goel R, Blake Z, Madhav KC, Matrana M, & Johnson D., Journal of Clinical Oncology, 5/2020
Cumulative steroid doses and response rates to immune checkpoint inhibitors in metastatic cancer.
Maslov DV, Tawagi K, Simenson V, Yuan H, Parent C, Bamnolker A, Goel R, Blake Z, Madhav KC, Matrana M, & Johnson D., Journal of Clinical Oncology, 5/2020
Join now to see all

Lectures

The misdiagnosis and treatment of Lipschutz ulcers as an active infectious process inducing neutropenia and delayed healing.
Touro University Nevada Annual Research Conference - 4/2018